» Articles » PMID: 33353064

Histone Variant H3.3 Mutations in Defining the Chromatin Function in Mammals

Overview
Journal Cells
Publisher MDPI
Date 2020 Dec 23
PMID 33353064
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The systematic mutation of histone 3 (H3) genes in model organisms has proven to be a valuable tool to distinguish the functional role of histone residues. No system exists in mammalian cells to directly manipulate canonical histone H3 due to a large number of clustered and multi-loci histone genes. Over the years, oncogenic histone mutations in a subset of H3 have been identified in humans, and have advanced our understanding of the function of histone residues in health and disease. The oncogenic mutations are often found in one allele of the histone variant H3.3 genes, but they prompt severe changes in the epigenetic landscape of cells, and contribute to cancer development. Therefore, mutation approaches using H3.3 genes could be relevant to the determination of the functional role of histone residues in mammalian development without the replacement of canonical H3 genes. In this review, we describe the key findings from the H3 mutation studies in model organisms wherein the genetic replacement of canonical H3 is possible. We then turn our attention to H3.3 mutations in human cancers, and discuss H3.3 substitutions in the N-terminus, which were generated in order to explore the specific residue or associated post-translational modification.

Citing Articles

H3K27me3 Loss in Central Nervous System Tumors: Diagnostic, Prognostic, and Therapeutic Implications.

Angelico G, Mazzucchelli M, Attanasio G, Tinnirello G, Farina J, Zanelli M Cancers (Basel). 2024; 16(20).

PMID: 39456545 PMC: 11506073. DOI: 10.3390/cancers16203451.


Histone H3 mutations and their impact on genome stability maintenance.

Caeiro L, Verdun R, Morey L Biochem Soc Trans. 2024; 52(5):2179-2191.

PMID: 39248209 PMC: 11580799. DOI: 10.1042/BST20240177.


Histone H3.3 lysine 9 and 27 control repressive chromatin at cryptic enhancers and bivalent promoters.

Trovato M, Bunina D, Yildiz U, Fernandez-Novel Marx N, Uckelmann M, Levina V Nat Commun. 2024; 15(1):7557.

PMID: 39214979 PMC: 11364623. DOI: 10.1038/s41467-024-51785-w.


Significance of Histone H3.3 (G34W)-Mutant Protein in Pathological Diagnosis of Giant Cell Tumor of Bone.

Miskad U, Syamsul F, Dahlan H, Sungowati N, Achmad D, Johan M Asian Pac J Cancer Prev. 2023; 24(5):1737-1741.

PMID: 37247296 PMC: 10495906. DOI: 10.31557/APJCP.2023.24.5.1737.


Histone 3.3-related chromatinopathy: missense variants throughout H3-3A and H3-3B cause a range of functional consequences across species.

Bryant L, Sangree A, Clark K, Bhoj E Hum Genet. 2023; 143(4):497-510.

PMID: 36867246 DOI: 10.1007/s00439-023-02536-2.


References
1.
Shen X, Liu Y, Hsu Y, Fujiwara Y, Kim J, Mao X . EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency. Mol Cell. 2008; 32(4):491-502. PMC: 2630502. DOI: 10.1016/j.molcel.2008.10.016. View

2.
Chen P, Zhao J, Wang Y, Wang M, Long H, Liang D . H3.3 actively marks enhancers and primes gene transcription via opening higher-ordered chromatin. Genes Dev. 2013; 27(19):2109-24. PMC: 3850095. DOI: 10.1101/gad.222174.113. View

3.
Musselman C, Lalonde M, Cote J, Kutateladze T . Perceiving the epigenetic landscape through histone readers. Nat Struct Mol Biol. 2012; 19(12):1218-27. PMC: 3645987. DOI: 10.1038/nsmb.2436. View

4.
Hake S, Garcia B, Duncan E, Kauer M, Dellaire G, Shabanowitz J . Expression patterns and post-translational modifications associated with mammalian histone H3 variants. J Biol Chem. 2005; 281(1):559-68. DOI: 10.1074/jbc.M509266200. View

5.
Xiong C, Wen Z, Yu J, Chen J, Liu C, Zhang X . UBN1/2 of HIRA complex is responsible for recognition and deposition of H3.3 at cis-regulatory elements of genes in mouse ES cells. BMC Biol. 2018; 16(1):110. PMC: 6171237. DOI: 10.1186/s12915-018-0573-9. View